drugset / Trial / NCT01549470
Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
RandomizedParallel-groupTriple-blindPrevention
Summary
Currently, no vaccine prevents HIV infection. This study will test the safety and immune responses of an HIV-1 DNA vaccine in HIV-uninfected adults in a Ugandan population.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2006-03
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VRC-HIVDNA009-00-VP | Vaccine | 4 mg/ml | Intramuscular |